Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GLOMERULAR DISEASE

Complex genetics of Alport and Goodpasture syndromes

Nature Reviews Nephrology volume 17, pages 635–636 (2021)Cite this article

Subjects

Proper glomerular basement membrane (GBM) structure and function are required for appropriate glomerular filtration and abnormalities in the α3α4α5 (α345) network of collagen IV — a GBM component — can lead to disease. New insights into the mechanisms underlying α345 hexamer assembly and function from genetic and structural data identify possible targets for therapeutic modulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Assembly of the collagen IV α3α4α5 network.

References

  1. Pokidysheva, E. N. et al. Collagen IVα345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture’s and Alport diseases. J. Biol. Chem. 296, 100590 (2021).

    Article  CAS  Google Scholar 

  2. Boudko, S. P. et al. Collagen IVα345 dysfunction in glomerular basement membrane diseases. II. Crystal structure of the α345 hexamer. J. Biol. Chem. 296, 100591 (2021).

    Article  CAS  Google Scholar 

  3. Pedchenko, V. et al. Collagen IVα345 dysfunction in glomerular basement membrane diseases. III. A functional framework for α345 hexamer assembly. J. Biol. Chem. 296, 100592 (2021).

    Article  CAS  Google Scholar 

  4. Hudson, B. G., Reeders, S. T. & Tryggvason, K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J. Biol. Chem. 268, 26033–26036 (1993).

    Article  CAS  Google Scholar 

  5. Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N. Engl. J. Med. 348, 2543–2556 (2003).

    Article  CAS  Google Scholar 

  6. Lin, M. H. et al. Laminin-521 protein therapy for glomerular basement membrane and podocyte abnormalities in a model of Pierson syndrome. J. Am. Soc. Nephrol. 29, 1426–1436 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular & Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore

    Karl Tryggvason

  2. Department of Medicine, Duke University, Durham, NC, USA

    Karl Tryggvason

  3. Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

    Karl Tryggvason

Authors
  1. Karl Tryggvason
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karl Tryggvason.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tryggvason, K. Complex genetics of Alport and Goodpasture syndromes. Nat Rev Nephrol 17, 635–636 (2021). https://doi.org/10.1038/s41581-021-00451-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-021-00451-1

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing